Candel Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $14,411,000.
Profit Margin
| 2019 | 125K | -8.01M | -6411.2% |
|---|---|---|---|
| 2020 | 125K | -22.17M | -17739.2% |
| 2021 | 125K | -36.17M | -28941.6% |
| 2022 | 125K | -2.86M | -2292.8% |
| 2023 | 0 | -37.93M |
CADL Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 0 | 125K | 125K | 125K | 125K |
Cost of revenue | 23.98M | 987K | 232K | 0 | 6.60M |
Gross profit | -23.98M | -862K | -107K | 125K | -6.48M |
Operating exp. | |||||
Research and development | 24.50M | 20.78M | 15.17M | 8.75M | 6.60M |
Selling and marketing | 687K | 0 | 0 | 0 | 0 |
Total operating expenses | 14.41M | 34.79M | 24.77M | 13.31M | 8.59M |
Operating income | -38.39M | -34.72M | -25.72M | -13.81M | -9.03M |
Other income (expenses), net | 452K | 15.92M | -10.39M | -3.87M | 797K |
Income before tax | -37.93M | -18.79M | -36.12M | -17.68M | -8.24M |
Income tax expense | 0 | -15.92M | 53K | 4.49M | -226K |
Net income | -37.93M | -2.86M | -36.17M | -22.17M | -8.01M |
Earnings per share | |||||
Basic EPS | -1.31 | -0.09 | -1.26 | -0.76 | -0.27 |
Diluted EPS | -1.31 | -0.09 | -1.26 | -0.76 | -0.27 |
| Data source | Data source | Data source |